1.
Eur Respir J
; 56(4)2020 10.
Article
in English
| MEDLINE
| ID: mdl-32444409
2.
Paediatr Respir Rev
; 26: 13-15, 2018 Mar.
Article
in English
| MEDLINE
| ID: mdl-28400242
ABSTRACT
A number of risk factors have been identified for deterioration of lung disease in children with Cystic Fibrosis (CF), and current management strategies are based on the prevention and treatment of such elements. Further challenge ensues when a patient has co-morbid disease in addition to CF, particularly when faced with rapidly deteriorating pulmonary status. It is difficult to measure the contribution of other pathologies to this decline and optimisation of both CF care and co-morbidity is paramount. This review explores the challenges faced when treating children with CF and co-morbid conditions, focussing on gastroesophageal reflux disease pre- and post-lung transplantation.